Thermo Fisher to buy Brammer Bio for about $1.7 bln
Thermo Fisher Scientific Inc said March 24 that it is buying Brammer Bio for approximately $1.7 billion in cash. Ampersand Capital Partners is the seller. Brammer Bio is a viral vector contract development and manufacturing organization.
25 March 2019•5 mins read
